RIGI and melanoma: 2Apro can specifically slice mitochondrial antiviral signaling (MAVS) protein, inactivating the antiviral innate immune response of retinoic acid-induced gene-I (RIG-I) and melanoma differentiation-associated gene, thereby lowering the production of Type I IFN (Wang et al., 2013).